EUVIMEDObjevte EUVIMED
FallberichtOpen access · CC BY 4.0

Size reduction of gastric fundic gland polyposis by de‐escalation of acid‐suppressive therapy

Akira Kanamori, Keiichi Tominaga iD, Hironori Masuyama, Mutsumi Ishikawa, Satoshi Masuyama, Masayuki Kondo, Mimari Kanazawa, Takanao Tanaka, Masamichi Yamaura, Keiichiro Abe, Shoko Watanabe, Akira Yamamiya and 3 more

DEN Open · 2023-04 · 3 (1)

DOI: 10.1002/deo2.135 ↗

At a glance

Fallbericht in DEN Open, published online on 2022-06-05. Written by Akira Kanamori and 14 co-authors. Institution: Department of Gastroenterology Dokkyo Medical University School of Medicine Tochigi Japan. Cited 3 times so far (Crossref); 10 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

The patient, a 73‐year‐old woman, had been taking acid‐suppressive therapy for refractory reflux esophagitis for 10 years. A potassium‐competitive acid blocker was administered to strengthen acid‐suppressive therapy for worsening symptoms of gastroesophageal reflux disease. Esophagogastroduodenoscopy showed an increase in the number and size of fundic gland polyposis (FGPs). When acid‐suppressive therapy was changed from potassium‐competitive acid blocker to proton pump inhibitor, the FGPs showed reduced size 1 year later. Furthermore, when acid‐suppressive therapy was changed from proton pump inhibitor to histamine‐2 receptor antagonist, FGPs were even smaller after 1 and 2 years. The patient, who had no flare‐up of gastroesophageal reflux disease symptoms, continues to be treated medically with histamine‐2 receptor antagonist. This case report describes changes in endoscopic findings of a patient with FGPs caused by acid‐suppressive therapy for refractory gastroesophageal reflux disease.

Subjects

Author keywords

acid‐suppressive therapyde‐escalationesophagogastroduodenoscopyfundic gland polyposis

Authors and institutions

  • Department of Gastroenterology Dokkyo Medical University School of Medicine Tochigi Japan.
  • Masuyama Gastrointestinal Clinic Tochigi Japan.

ORCID profiles: Keiichi Tominaga

Cite

APA

Kanamori, A., Tominaga, K., Masuyama, H., Ishikawa, M., Masuyama, S., Kondo, M., Kanazawa, M., Tanaka, T., Yamaura, M., Abe, K., Watanabe, S., Yamamiya, A., Abe, Y., Goda, K., & Irisawa, A. (2023). Size reduction of gastric fundic gland polyposis by de‐escalation of acid‐suppressive therapy. DEN Open, 3(1). https://doi.org/10.1002/deo2.135

Vancouver

Kanamori A, Tominaga K, Masuyama H, Ishikawa M, Masuyama S, Kondo M, et al. Size reduction of gastric fundic gland polyposis by de‐escalation of acid‐suppressive therapy. DEN Open. 2023;3(1). doi:10.1002/deo2.135

BibTeX
@article{Kanamori2023,
  author = {Kanamori, Akira and Tominaga, Keiichi and Masuyama, Hironori and Ishikawa, Mutsumi and Masuyama, Satoshi and Kondo, Masayuki and Kanazawa, Mimari and Tanaka, Takanao and Yamaura, Masamichi and Abe, Keiichiro and Watanabe, Shoko and Yamamiya, Akira and Abe, Yoko and Goda, Kenichi and Irisawa, Atsushi},
  title = {Size reduction of gastric fundic gland polyposis by de‐escalation of acid‐suppressive therapy},
  journal = {DEN Open},
  year = {2023},
  volume = {3},
  number = {1},
  doi = {10.1002/deo2.135}
}
Start for free →